TERT and neoplasm: Indeed, while patients with the -124 C>T TERT promoter mutation had a higher risk of mucosal failure and poorer DFS and OS, patients with tumours harbouring the -146 C>T mutation had an improved clinical outcome, similar to those with unmutated TERT promoter.